SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-045474
Filing Date
2023-12-19
Accepted
2023-12-19 17:57:08
Documents
1
Period of Report
2023-12-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7108
  Complete submission text file 0001493152-23-045474.txt   8742
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Issuer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SENECA BIOPHARMA, INC. 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address
Finley John David (Reporting) CIK: 0001851034 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33672 | Film No.: 231498742